These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24347784)

  • 41. Intravenous Iron Sucrose versus Oral Iron in the Treatment of Pregnancy with Iron Deficiency Anaemia: A Systematic Review.
    Shi Q; Leng W; Wazir R; Li J; Yao Q; Mi C; Yang J; Xing A
    Gynecol Obstet Invest; 2015; 80(3):170-8. PubMed ID: 25824489
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Parenteral iron therapy.
    Kaplinsky C
    Isr Med Assoc J; 2008 May; 10(5):372-3. PubMed ID: 18605363
    [No Abstract]   [Full Text] [Related]  

  • 43. Association of different intravenous iron preparations with risk of bacteremia in maintenance hemodialysis patients.
    Sirken G; Raja R; Rizkala AR
    Clin Nephrol; 2006 Nov; 66(5):348-56. PubMed ID: 17140164
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Management of iron deficiency anaemia in gynaecological patients at Jinnah Postgraduate Medical Centre, Karachi.
    Nasir A; Yasmin H; Korejo R
    J Pak Med Assoc; 2011 Oct; 61(10):998-1001. PubMed ID: 22356035
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy.
    Hetzel D; Strauss W; Bernard K; Li Z; Urboniene A; Allen LF
    Am J Hematol; 2014 Jun; 89(6):646-50. PubMed ID: 24639149
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of intravenous iron in anemia management and transfusion avoidance.
    Auerbach M; Goodnough LT; Picard D; Maniatis A
    Transfusion; 2008 May; 48(5):988-1000. PubMed ID: 18346021
    [No Abstract]   [Full Text] [Related]  

  • 47. Intravenous iron monotherapy for the treatment of non-iron-deficiency anemia in cancer patients undergoing chemotherapy: a pilot study.
    Abdel-Razeq H; Abbasi S; Saadi I; Jaber R; Abdelelah H
    Drug Des Devel Ther; 2013; 7():939-44. PubMed ID: 24039403
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative Risk of Anaphylactic Reactions Associated With Intravenous Iron Products.
    Wang C; Graham DJ; Kane RC; Xie D; Wernecke M; Levenson M; MaCurdy TE; Houstoun M; Ryan Q; Wong S; Mott K; Sheu TC; Limb S; Worrall C; Kelman JA; Reichman ME
    JAMA; 2015 Nov; 314(19):2062-8. PubMed ID: 26575062
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intravenous iron sucrose v/s oral ferrous fumarate for treatment of anemia in pregnancy. A randomized controlled trial.
    Bhavi SB; Jaju PB
    BMC Pregnancy Childbirth; 2017 May; 17(1):137. PubMed ID: 28482869
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of intravenous and oral iron administration on perioperative anaemia and transfusion requirements in patients undergoing elective cardiac surgery: a randomized clinical trial.
    Garrido-Martín P; Nassar-Mansur MI; de la Llana-Ducrós R; Virgos-Aller TM; Rodríguez Fortunez PM; Ávalos-Pinto R; Jimenez-Sosa A; Martínez-Sanz R
    Interact Cardiovasc Thorac Surg; 2012 Dec; 15(6):1013-8. PubMed ID: 22940889
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A permanent tan from iron.
    Lim R; Irvine T; Ahmed MS; Abraham K; Wong CF
    Kidney Int; 2008 Apr; 73(7):898. PubMed ID: 18340355
    [No Abstract]   [Full Text] [Related]  

  • 52. A rare occurrence of intrauterine death following an allergic reaction to iron sucrose.
    Basavareddy A
    Indian J Pharmacol; 2020; 52(1):53-55. PubMed ID: 32201448
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chronic kidney disease: Serious adverse effects associated with IV iron in CKD.
    Allison SJ
    Nat Rev Nephrol; 2015 Sep; 11(9):506. PubMed ID: 26149838
    [No Abstract]   [Full Text] [Related]  

  • 54. Triferic for iron replacement.
    Med Lett Drugs Ther; 2017 Mar; 59(1517):55-56. PubMed ID: 28323812
    [No Abstract]   [Full Text] [Related]  

  • 55. Pulmonary edema: atypical anaphylactoid reaction to intravenous iron dextran.
    Freter S; Davidman M; Lipman M; Bercovitch D
    Am J Nephrol; 1997; 17(5):477-9. PubMed ID: 9382172
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Low-molecular weight iron dextran and iron sucrose have similar comparative safety profiles in chronic kidney disease.
    Auerbach M; Al Talib K
    Kidney Int; 2008 Mar; 73(5):528-30. PubMed ID: 18274543
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oral iron.
    Nurs Times; 2006 Jun 27-Jul 3; 102(26):40. PubMed ID: 16845816
    [No Abstract]   [Full Text] [Related]  

  • 58. Iron sucrose - characteristics, efficacy and regulatory aspects of an established treatment of iron deficiency and iron-deficiency anemia in a broad range of therapeutic areas.
    Beguin Y; Jaspers A
    Expert Opin Pharmacother; 2014 Oct; 15(14):2087-103. PubMed ID: 25186219
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of serum ferritin and transferrin saturation values associated with two i.v. iron formulations in hemodialysis patients.
    Nguyen TV
    Am J Health Syst Pharm; 2009 Jun; 66(12):1101-4. PubMed ID: 19498125
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Newly diagnosed iron deficiency anemia in a premenopausal woman].
    Todd T; Caroe T
    Praxis (Bern 1994); 2008 Jun; 97(13):735-6. PubMed ID: 18770926
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.